Polynovo Limited (CALZF) Stock
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Polynovo Limited
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the United States of America, Australia and New Zealand, and Other Countries geographical segments. The company was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.
Polynovo Limited is headquartered in AU.
Polynovo Limited (CALZF) stock trades at $0.56 with a market capitalization of $386.87M. The stock is valued at a price-to-earnings (P/E) ratio of 61.19, price-to-book of 7.27, price-to-sales of 4.38. Over the past 52 weeks the stock has ranged between $0.55 and $1.02, and currently trades 45.1% below its 52-week high.
On profitability, Polynovo Limited generates a return on equity (ROE) of 11.87%, return on capital employed of 2.72%, an operating margin of 1.98%, a net profit margin of 7.16%.
Official website: polynovo.com